Format
Sort by
Items per page

Send to

Choose Destination

Best matches for malignant neoplasm of breast AND mammography AND mri of breast:

Search results

Items: 1 to 20 of 2617

1.

Utilization of breast cancer screening with magnetic resonance imaging in community practice.

Hill DA, Haas JS, Wellman R, Hubbard RA, Lee CI, Alford-Teaster J, Wernli KJ, Henderson LM, Stout NK, Tosteson ANA, Kerlikowske K, Onega T.

J Gen Intern Med. 2017 Dec 6. doi: 10.1007/s11606-017-4224-6. [Epub ahead of print]

PMID:
29214373
2.

Erythematous, friable nipple with loss of protrusion · history of breastfeeding · Dx?

Baumgarten HD, Showalter SL, Rochman CM, Keim-Malpass J.

J Fam Pract. 2017 Dec;66(12):758-760.

PMID:
29202150
3.

Can diffusion-weighted imaging add information in the evaluation of breast lesions considered suspicious on magnetic resonance imaging?

Guatelli CS, Bitencourt AGV, Osório CABT, Graziano L, de Castro AA, de Souza JA, Marques EF, Chojniak R.

Radiol Bras. 2017 Sep-Oct;50(5):291-298. doi: 10.1590/0100-3984.2016.0089.

4.

Screening for Breast Cancer.

Niell BL, Freer PE, Weinfurtner RJ, Arleo EK, Drukteinis JS.

Radiol Clin North Am. 2017 Nov;55(6):1145-1162. doi: 10.1016/j.rcl.2017.06.004. Review.

PMID:
28991557
5.

JOURNAL CLUB: Diagnostic Utility of MRI After Negative or Inconclusive Mammography for the Evaluation of Pathologic Nipple Discharge.

Bahl M, Gadd MA, Lehman CD.

AJR Am J Roentgenol. 2017 Dec;209(6):1404-1410. doi: 10.2214/AJR.17.18139. Epub 2017 Sep 12.

PMID:
28898125
6.

Accuracy of contrast-enhanced spectral mammography for estimating residual tumor size after neoadjuvant chemotherapy in patients with breast cancer: a feasibility study.

Barra FR, de Souza FF, Camelo REFA, Ribeiro ACO, Farage L.

Radiol Bras. 2017 Jul-Aug;50(4):224-230. doi: 10.1590/0100-3984.2016-0029.

7.

Accuracy of screening women at familial risk of breast cancer without a known gene mutation: Individual patient data meta-analysis.

Phi XA, Houssami N, Hooning MJ, Riedl CC, Leach MO, Sardanelli F, Warner E, Trop I, Saadatmand S, Tilanus-Linthorst MMA, Helbich TH, van den Heuvel ER, de Koning HJ, Obdeijn IM, de Bock GH.

Eur J Cancer. 2017 Nov;85:31-38. doi: 10.1016/j.ejca.2017.07.055. Review.

PMID:
28886475
8.

Value of a short-term imaging follow-up after a benign result in a one-stop breast unit: Is it still useful?

Daroles J, Borget I, Suciu V, Mazouni C, Delaloge S, Balleyguier C.

Eur J Cancer. 2017 Nov;85:23-30. doi: 10.1016/j.ejca.2017.08.002. Epub 2017 Sep 4.

PMID:
28881248
9.

BRCA Genetic Testing and Receipt of Preventive Interventions Among Women Aged 18-64 Years with Employer-Sponsored Health Insurance in Nonmetropolitan and Metropolitan Areas - United States, 2009-2014.

Kolor K, Chen Z, Grosse SD, Rodriguez JL, Green RF, Dotson WD, Bowen MS, Lynch JA, Khoury MJ.

MMWR Surveill Summ. 2017 Sep 8;66(15):1-11. doi: 10.15585/mmwr.ss6615a1.

PMID:
28880857
10.

Could parenchymal enhancement on contrast-enhanced spectral mammography (CESM) represent a new breast cancer risk factor? Correlation with known radiology risk factors.

Savaridas SL, Taylor DB, Gunawardana D, Phillips M.

Clin Radiol. 2017 Dec;72(12):1085.e1-1085.e9. doi: 10.1016/j.crad.2017.07.017. Epub 2017 Sep 1.

PMID:
28870431
11.

Can magnetic resonance imaging obviate the need for biopsy for microcalcifications?

Yamamoto S, Chishima T.

Gland Surg. 2017 Aug;6(4):302-307. doi: 10.21037/gs.2017.03.14.

12.

Association of BRCA Mutation Types, Imaging Features, and Pathologic Findings in Patients With Breast Cancer With BRCA1 and BRCA2 Mutations.

Ha SM, Chae EY, Cha JH, Kim HH, Shin HJ, Choi WJ.

AJR Am J Roentgenol. 2017 Oct;209(4):920-928. doi: 10.2214/AJR.16.16957. Epub 2017 Aug 10.

PMID:
28796549
13.

Utility of BI-RADS Assessment Category 4 Subdivisions for Screening Breast MRI.

Strigel RM, Burnside ES, Elezaby M, Fowler AM, Kelcz F, Salkowski LR, DeMartini WB.

AJR Am J Roentgenol. 2017 Jun;208(6):1392-1399. doi: 10.2214/AJR.16.16730.

PMID:
28792802
14.

Factors predictive of occult nipple-areolar complex involvement in patients with carcinoma in situ of the breast.

Hwang H, Park S, Koo JS, Park HS, Kim SI, Cho YU, Park BW, Yoon JH, Kim MJ, Kim EK.

J Surg Oncol. 2017 Jul 25. doi: 10.1002/jso.24768. [Epub ahead of print]

PMID:
28743180
15.

The HIQA's Health Technology Assessment of Breast Screening: Highlighting Some of the Challenges Posed by Evaluations of Screening Programs.

Teljeur C, Moran P, Harrington P, Ryan M.

Value Health. 2017 Jul - Aug;20(7):1000-1002. doi: 10.1016/j.jval.2016.11.024. Epub 2017 Jan 13.

PMID:
28712610
16.

Role of breast magnetic resonance imaging in predicting malignant invasion of the nipple-areolar complex: Potential predictors and reliability between inter-observers.

Liao CY, Wu YT, Wu WP, Chen CJ, Wu HK, Lin YJ, Chen ST, Chen DR, Lee CW, Chen SL, Kuo SJ, Lai HW.

Medicine (Baltimore). 2017 Jul;96(28):e7170. doi: 10.1097/MD.0000000000007170.

17.

Maximum intensity breast diffusion MRI for BI-RADS 4 lesions detected on X-ray mammography.

Bickelhaupt S, Paech D, Laun FB, Steudle F, Kuder TA, Mlynarska A, Bach M, Lederer W, Teiner S, Schneider S, Ladd ME, Daniel H, Stieber A, Kopp-Schneider A, Delorme S, Schlemmer HP.

Clin Radiol. 2017 Oct;72(10):900.e1-900.e8. doi: 10.1016/j.crad.2017.05.017. Epub 2017 Jul 4.

PMID:
28687167
18.

Breast Cancer Screening With Mammography Plus Ultrasonography or Magnetic Resonance Imaging in Women 50 Years or Younger at Diagnosis and Treated With Breast Conservation Therapy.

Cho N, Han W, Han BK, Bae MS, Ko ES, Nam SJ, Chae EY, Lee JW, Kim SH, Kang BJ, Song BJ, Kim EK, Moon HJ, Kim SI, Kim SM, Kang E, Choi Y, Kim HH, Moon WK.

JAMA Oncol. 2017 Nov 1;3(11):1495-1502. doi: 10.1001/jamaoncol.2017.1256.

PMID:
28655029
19.

Newly Diagnosed Breast Cancer: Comparison of Contrast-enhanced Spectral Mammography and Breast MR Imaging in the Evaluation of Extent of Disease.

Lee-Felker SA, Tekchandani L, Thomas M, Gupta E, Andrews-Tang D, Roth A, Sayre J, Rahbar G.

Radiology. 2017 Nov;285(2):389-400. doi: 10.1148/radiol.2017161592. Epub 2017 Jun 26.

PMID:
28654337
20.

Ultrasound-guided cable-free 13-gauge vacuum-assisted biopsy of non-mass breast lesions.

Seo J, Kim SM, Jang M, Yun B, Lee SH, Kim EK, Kang E, Park SY, Moon WK, Choi HY, Kim B.

PLoS One. 2017 Jun 19;12(6):e0179182. doi: 10.1371/journal.pone.0179182. eCollection 2017.

Supplemental Content

Loading ...
Support Center